Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemel A, et al. Global Cancer Statistics 2018: globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018;68(6):394-424.
Global Cancer Observatory, World Health Organisation, International Agency for Research on Cancer. [internet]. Available from: https://gco.iarc.fr
Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical Cancer in Africa, Latin America and the Caribbean and Asia: Regional Inequalities and Changing Trends. Int J Cancer. 2017;141(10):1997-2001. Doi: https://doi.org/10.1002/ijc.30901
Organización Panamericana de la Salud. Cáncer cervicouterino [Internet] 2016. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article&id=5420%3A2011-cervical-cancer&catid=1872%3Acancer&Itemid=3637=es
Huertas J, Rivillas-García J, Ospina M. Progreso en el logro de los objetivos de desarrollo del milenio: la mortalidad por cáncer de cérvix desciende en Colombia. Rev Fac Nac Salud Pública;2015; 33(2): 286-90. Doi: 10.17533/udea.rfnsp.v33n2a15
Bernard V, Watson M, Castle P, Saraiya M. Cervical Carcinoma Rates Among Young Females in the United States. Obstet Gynecol. 2012;120(5):1117-1123.
Departamento Administrativo Nacional de Estadística, Colombia. Estadísticas vitales, causas de defunción no fetal. Muertes por causa 20.9 “Tumores del Útero” - Causas agrupadas 6/67 OPS. Available from: http://microdatos.dane.gov.co/index.php/catalog/MICRODATOS/about_collection/22/5
Walboomers J, Jacobs M, Manos M, Bosch F, Kummer J, Shah K et al. Human Papillomavirus Is a Necessary Cause of Invasive Cervical Cancer Worldwide. J Pathol. 1999;189(1):12-9. Doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
De San José S, Bosh F, Castellsagué X. Epidemiología de la infección por vph y del cáncer de cuello de útero. semergen. 2007;33 Supl 2:9-21.
Castellsagué X, De San José S, Bosch F. Epidemiología de las infecciones por el virus del papiloma humano: nuevas opciones para la prevención del cáncer cervicouterino. In: Alonso P, Lascano E, Hernández M, eds. Cáncer cervicouterino: diagnóstico, prevención y control. 2° ed. México: Editorial Médica Panamericana; 2005. p. 203-15.
Almonte M, Albero G, Molano M, Carcamo C, Garcìa P, Pérez G et al. Risk Factors for Human Papillomavirus Exposure and Co-Factors for Cervical Cancer in Latin America and the Caribbean. Vaccine 2008;26 (Suppl 11):L16-36. Doi: 10.1016/j.vaccine.2008.06.008
Castellsagué X, Bosch F, Muñoz N. Environmental Co-Factors in hpv Carcinogenesis. Virus Res. 2002;89(2):191-9.
Ribeiro A, Costa M, Alves R, Villa L, Saddi V, Carneiro M, et al. hpv Infection and Cervical Neoplasia: Associated Risk Factors. Infect Agent Cancer. 2015;10:16. Doi: 10.1186/s13027-015-0011-3
Partridge J, Hughes J, Feng Q, Winer R, Weaver B, Xi L et al. Genital Human Papillomavirus Infection in Men: Incidence and Risk Factors in a Cohort of University Students. J Infect Dis. 2007;196(8):1128-36. Doi: 10.1086/521192
Barrasso R, De Brux J, Croissant O, Orth G. High Prevalence of Papillomavirus-Associated Penile Intraepithelial Neoplasia in Sexual Partners of Women with Cervical Intraepithelial Neoplasia. N Engl J Med. 1987;317(15):916-23. Doi:10.1056/NEJM198710083171502
Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron et al. Incidence and Clearance of Genital Human Papillomavirus Infection in Men (HIM): A Cohort Study. Lancet 2011;377(9769):932-40. Doi: 10.1016/S0140-6736(10)62342-2
Louie KS, De Sanjose S, Díaz M, Castellsagué X, Herrero R, Meijer CJ. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Early Age at First Sexual Intercourse and Early Pregnancy Are Risk Factors for Cervical Cancer in Developing Countries. Br J Cancer. 2009;100(7):1191-1197. Doi: 10.1038/sj.bjc.6604974
Appleby P, Beral V, Berrington de González A, Collin D, Franceschi S, Goodill A, et al. Carcinoma of the Cervix and Tobacco Smoking: Collaborative Reanalysis of Individual Data on 13,541 Women with Carcinoma of the Cervix and 23,017 Women without Carcinoma of the Cervix from 23 Epidemiological Studies. Int J Cancer. 2006;118(6):1481-95. Doi: 10.1002/ijc.21493.
Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, et al. Smoking as a Major Risk Factor for Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. Int. J. Cancer 2013;135: 453-466. Doi: 10.1002/ijc.28666
Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, et al. Smoking and Human Papillomavirus Infection: Pooled Analysis of the International Agency for Research on Cancer hpv Prevalence Surveys. Int J Epidemiol 2008;37:536–46. Doi: 10.1093/ije/dyn033
Poppe W, Ide P, Drijkoningen M, Lauweyns J, Van Assche F. Tobacco Smoking Impairs the Local Immunosurveillance in the Uterine Cervix. An Immunohistochemical Study. Gynecol Obstet Invest. 1995;39(1):34-8. Doi: 10.1159/000292372
Lee P, Thornton A, Hamling J. Epidemiological Evidence on Environmental Tobacco Smoke and Cancers Other than Lung or Breast. Regul Toxicol Pharmacol. 2016;80:134-63. Doi: 10.1016/j.yrtph.2016.06.012
Eldridge R, Pawlita M, Wilson L, Castle P, Waterboer T, Gravitt P, et al. Smoking and Subsequent Human Papillomavirus Infection: A Mediation Analysis. Ann Epidemiol. 2017;27(11):724-30.e1. Doi: 10.1016/j.annepidem.2017.10.004
Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S et al. Human Papilloma Virus: Apprehending the Link with Carcinogenesis and Unveiling New Research Avenues (Review). Int J Oncology 2018;52(3):637-655. Doi: https://doi.org/10.3892/ijo.2018.4256
Silva J, Cerqueira F, Medeiros R. Chlamydia Trachomatis Infection: Implications for hpv Status and Cervical Cancer. Arch Gynecol Obstet. 2014;289(4):715-23. Doi: 10.1007/s00404-013-3122-3
Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Chlamydia Trachomati Infection-Associated Risk of Cervical Cancer. A Meta-Analysis. Medicine (Baltimore). 2016;95(13): e3077. Doi: 10.1097/MD.0000000000003077
Departamento de Salud y Servicios Humanos de los Estados Unidos – Centros para el Control y la Prevención de Enfermedades (CDC). Los condones y las ETS: Hoja informativa para el personal de salud pública. Available from: https://www.cdc.gov/condomeffectiveness/docs/Condoms_and_STDS_spanish.pdf
Castellsagué X, Ault KA, Bosch X, Brown D, Cuzick J, Ferris DG, et al. Human Papillomavirus Detection in Cervical Neoplasia Attributed to 12 High-Risk Human Papillomavirus Genotypes by Region. Papillomavirus Res. 2016; 2: 61–69. Doi: 10.1016/j.pvr.2016.03.002
Grund JM, Bryant TS, Jackson I, Curran K, Bock N, Toledo C, et al. Association between Male Circumcision and Women’s Biomedical Health Outcomes: A Systematic Review. Lancet Glob Health 2017; 5: e1113–22. Doi: https://doi.org/10.1016/S2214-109X(17)30369-8
Landy R, Pesola F, Castañón A, Sasieni P. Impact of Cervical Screening on Cervical Cancer Mortality: Estimation Using Stage-Specific Results from a Nested Case-Control Study. Br J Cancer. 2016;115(9):1140–1146. Doi: 10.1038/bjc.2016.290
Instituto Nacional de Cancerología-ESE, Sistema General de Seguridad Social en Salud Colombia. Guía de práctica clínica para la detección y manejo de lesiones precancerosas de cuello uterino – 2014. Guía Nr. 45 para profesionales de la salud. Available from: http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Otros_conv/GPC_cuello_uterino_inv/CCU_Guia_profesionales_julio_2016.pdf
Chatzistamatiou K, Moysiadis T, Moschaki V, Panteleris N, Agorastos T. Comparison of Cytology, HPV DNA testing and HPV 16/18 Genotyping Alone or Combined Targeting to the More Balanced Methodology for Cervical Cancer Screening. Gynecol Oncol. 2016;42(1):120-127. Doi: 10.1016/j.ygyno.2016.04.027
Canadian Partnership Against Cancer. New Cervical Cancer Screening Guidelines. Shifting from Overscreening Young Women to Minimize Harms [December 20, 2016]. Available from: https://www.partnershipagainstcancer.ca/news-events/news/article/cervical-cancer-new-guidelines-shifting-overscreening-young-women/
Vesco K, Whitlock E, Eder M, Burda BU, Senger CA, Lutz K. Risk Factors and other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(10):698-705. Doi: 10.7326/0003-4819-155-10-201111150-00377
Urrutia MT. Cáncer cervicouterino en Chile: análisis de un nuevo paradigma preventivo. Universidad de Chile, Temas de la agenda pública 2015;78. Available from: https://politicaspublicas.uc.cl/wp-content/uploads/2015/06/N%C2%B0-78-C%C3%A1ncer-cervicouterino.-Nuevo-paradigama-preventivo..pdf
Asociación Española de Patología Cervical y Colposcopia. Guía de cribado del cáncer de cuello de útero en España 2014. Asociación Española de Patología Cervical y Colposcopia. isbn: 978-84-608-3655-1. Available from: http://www.aepcc.org/wp-content/uploads/2015/05/AEPCC_revista01.pdf
US Preventive Services Task Force: Curry S, Krist A, Owens D, Barry J, Caughey A, Davidson K. Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement. jama. 2018;320(7):674-686. Doi:10.1001/jama.2018.10897
European Comission against Cancer, International Agency for Research on Cancer. Cancer Screening in the European Unión 2017. Report on the Implementation of the Council Recommendation on Cancer Screening. p. 132. Available from: https://ec.europa.eu/health/sites/health/files/major_chronic_diseases/docs/2017_cancerscreening_2ndreportimplementation_
en.pdf
Vargas-Hernández VM. Estado cambiante del tamizaje en cáncer cérvico-uterino Rev Enf Trac Gen Inf 2018;11(1-4):4-6. Available from: http://www.comegic.org.mx/wp-content/uploads/2018/05/Tracto-Genital-1-18.pdf
Lee M, Finlayson S, Gukova K, Hanley G, Miller D, Sadownik L. Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young Women. J Low Genit Tract Dis. 2018 Jul; 22(3): 212–218. Doi: 10.1097/LGT.0000000000000399
Moscicki AB. Cervical Cytology Screening in Teens. Curr Womens Health Rep. 2003;3:433-437.
Zhang S, Thomas J, Thibodeaux J, Bhalodia A, Abreo F. Teenage Cervical Screening in a High Risk American Population. Cytojournal 2011;8:9. Doi: 10.4103/1742-6413.81773
Vash-Margita A, Flagler EN, Kobernik EK, Quint EH, Dalton VK. Trends in Cervical Cancer Screening in Adolescents. J Pediatr Adol Gynec 2017;30(2): 293–294. Doi: https://doi.org/10.1016/j.jpag.2017.03.056
Del Río-Ospina L, Soto-De León SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, et al. The Prevalence of High-Risk hpv Types and Factors Determining Infection in Female Colombian Adolescents. PLoS ONE. 2016;11(11):e0166502. Doi: https://doi.org/10.1371/journal.pone.0166502
Michala L, Argyri E, Tsimplaki E, Tsitsika A, Bakoula C, Antsaklis A, et al. Human Papilloma Virus Infection in Sexually Active Adolescent Girls. Gynecol Oncol. 2012;126(2):207-10. Doi: 10.1016/j.ygyno.2012.04.042
Posso A, Rangel M, Marchán N, González M. Lesión intraepitelial cervical en adolescentes. Rev Obstet Ginecol Venez. 2014;74(3):193-202.
Mendoza L, Arias G, Pedroza P, Micolta P, Ramírez A, Cáceres C, et al. Actividad sexual en adolescencia temprana: problema de salud pública en una ciudad colombiana. Rev. Chil. Obstet. Ginecol. 2012;77(4):271-279. Doi: 10.4067/S0717-75262012000400006
Saleh MM, Seoud AA, Zaklama MS. Abnormal Cervical Smears in Adolescents: A Ten-Year Comparative Study of Demographic Criteria and Management. Clin Exp Obstet Gynecol 2007;34(3):139-42.
Jayasinghe Y, Moore E, Tabrizi S, Grover S, Garland S. Human Papillomavirus in Adolescents: Lessons Learned from Decades of Evaluation. J Paediatr Child Health. 2013;49(2):99-104. Doi: 10.1111/j.1440-1754.2011.02073.x
Moscicki AB. Cervical Cytology Screening in Teens. Curr Womens Health Rep. 2003;3:433-437.
Farid ND, Rus SC, Dahlui M, Al-Sadat N, Aziz NA. Predictors of Sexual Risk Behaviour among Adolescents from Welfare institutions in Malaysia: A Cross Sectional Study. bmc Public Health. 2014;14 Suppl 3:S9. Doi: 10.1186/1471-2458-14-S3-S9
Leung H, Lin L. Adolescent Sexual Risk Behavior in Hong Kong: Prevalence, Protective Factors, and Sex Education Programs. J Adolescent Health June 2019;64(6) Suppl: S52-S58 Doi: 10.1016/j.jadohealth.2018.12.007
Dallenbach G, Knebel M, Trunk M. Histopatología del cuello uterino. Atlas a color, 2º ed. Journal Buenos Aires 2006 p VII y VIII, 209 p.
Vargas-Hernández VM, Acosta-Altamirano G, Vargas-Aguilar VM. New Guidelines in Regard to Cervical Cáncer Screening. Cir Cir 2014;82(4):453-459
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Available from: https://pdfs.semanticscholar.org/a827/571a281d0c8e10dda68991622b7b0f0d67a7.pdf
Ministerio de Salud y Protección Social. Colombia. Resolución No. 003280 de 2 agosto de 2018, p 168. Available from: http://legal.legis.com.co/document/Index?obra=legcol&
document=legcol_f63a1888c06e48a981ffa9117bc9129b
